SHINE's fusion platform is already generating revenue
It earns from neutron testing, medical isotope manufacturing, and waste recycling, as highlighted at FusionX:Americas.
See the latest news and media coverage for SHINE. We track all announcements, press releases, and industry mentions in real time, all in one place.
Nuclear fusion technology developer
shinefusion.comLast updated
In short: SHINE Technologies secured a $263M DOE loan, raised $240M in funding, and gained EU marketing authorization for its Ilumira Lu-177 radioisotope.
It earns from neutron testing, medical isotope manufacturing, and waste recycling, as highlighted at FusionX:Americas.
They will explore supplying recovered materials for MOX fuel and recycling spent fuel from newcleo's reactors.
The proposal involves processing surplus plutonium to recover americium for radioisotope applications and purifying the rest for advanced reactor fuel, partnering with Zeno Power and Orano.
The approval opens the EU market for non-carrier-added Lu-177, supporting radioligand therapy development.
Next-generation fusion specialist SHINE Technologies has secured centralised marketing authorisation...
SHINE Technologies has been competitively selected by the U.S. Department of Energy for advanced negotiations to convert surplus plutonium ? material originally produced for U.S...
The loan would go toward SHINE Technologies’ vast medical isotope production facility in Janesville.
The award to SHINE Chrysalis LLC, through the Department of Energy's Office of Energy Dominance Financing, is dependent on the company satisfying technical, legal, environmental...
Track SHINE and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.
Discover what's making headlines across other trending companies.